MD HB736 | 2024 | Regular Session

Status

Spectrum: Strong Partisan Bill (Democrat 18-1)
Status: Introduced on January 29 2024 - 25% progression
Action: 2024-02-26 - Withdrawn by Sponsor
Text: Latest bill text (Introduced) [PDF]

Summary

Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal Food and Drug Administration for the complete or partial reversal of an opioid overdose without imposing a copayment or coinsurance requirement that exceeds $10 per package.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Health Insurance and Maryland Medical Assistance Program - Coverage - Opioid Reversal Drugs and Products (NARCAN Price Cap Act)

Sponsors


History

DateChamberAction
2024-02-26HouseWithdrawn by Sponsor
2024-02-05HouseHearing 2/15 at 1:00 p.m.
2024-01-29HouseFirst Reading Health and Government Operations

Same As/Similar To

SB497 (Crossfiled) 2024-03-04 - Withdrawn by Sponsor

Subjects


Code Citations

ChapterArticleSectionCitation TypeStatute Text
Health - General15102.3(n/a)See Bill Text
Health - General15103(n/a)See Bill Text
Insurance15850.1(n/a)See Bill Text

Maryland State Sources


Bill Comments

feedback